PPARGC1A and lung carcinoma: Several studies have confirmed that some drug-resistant tumor cells are particularly strongly dependent on PGC-1α-mediated metabolic activity, and the inhibition of PGC-1α expression sensitizes some tumor cells to treatment, including lung cancer cells (153).